25.08.1969, Makow Mazowiecki, Poland

Grammar School, Ostroleka, Poland

the Faculty of Medicine, Medical University in Warsaw, Poland

the Faculty of Medicine, Medical University in Bialystok, Poland

PhD degree in medical sciences, on the basis of the thesis entitled „The mechanism of antithrombotic action of captopril in venous thrombosis in rats"

Specialization in internal diseases

Second Department of Physiology, Hamamatsu University School of Medicine, Fellowship of the Ministry of Education, Science and Culture of Japan

Professional experience:

Prefectural General Hospital in Bialystok, Poland, postgraduate training

Clinic of Nephrology and Internal Diseases, Medical University in Bialystok, Poland, physician

Second Department of Physiology, Hamamatsu University School of Medicine, Fellowship of the Ministry of Education, Science and Culture of Japan

Second Department of Physiology, Hamamatsu University School of Medicine, invited researcher

Department of Pharmacodynamics, Medical University of Bialystok, assistant

Department of Pharmacodynamics, Medical University of Bialystok, assistant professor

Laboratory of Neurobiology and Genetics, Rockefeller University, New York, postdoctoral associate

The Award for the Excellence in Research, from the President of the Medical University of Bialystok, Poland

1. Pawlak R, Napiorkowska-Pawlak D, Takada Y, Urano T, Nagai N, Ihara H, Takada A: The differential effect of angiotensin II and angiotensin 1-7 on norepinephrine, epinephrine, and dopamine concentrations in rat hypothalamus: the involvement of angiotensin receptors. Brain Res Bull , in press
2. Gruszecki M, Rółkowski R, Pawlak R, Buczko W: Propranolol prevents the development of venous thrombosis in rats by a platelet-dependent mechanism. Pol J Pharmacol 2001, 53: 5-10
3. Matys T, Chabielska E, Pawlak R, Kucharewicz I, Buczko W: Losartan inhibits the adhesion of rat platelets to fibrillar collagen--a potential role of nitric oxide and prostanoids. J Physiol Pharmacol 2000 Dec;51(4 Pt 1):705-13
4. Pawlak R, Chabielska E, Matys T, Kucharewicz I, Rółkowski R, Buczko W. Thiol repletion prevents venous thrombosis in rats by nitric oxide/prostacyclin-dependent mechanism: relation to the antithrombotic action of captopril. J Cardiovasc Pharmacol 2000, 34(4): 503-9
5. Pawlak R, Chabielska E, Matys T, Kucharewicz I, Buczko W. The role of thiol group in the antithrombotic action of captopril. Thromb Haemost 2000, 84: 919-20
6. Matys T, Pawlak R, Kucharewicz I, Chabielska E, Buczko W. Hypotensive effect of angiotensin II after AT1-receptor blockade with losartan. J Physiol Pharmacol 2000 Mar;51(1):161-6
7. Napiorkowska-Pawlak D, Malinowska B, Pawlak R, Buczko W, Gothert M. Attenuation of the acute amnestic effect of ethanol by ifenprodil: comparison with ondansetron and dizocilpine. Fundam Clin Pharmacol 2000 Mar-Apr;14(2):125-31
8. Minowa K, Pawlak R, Takada Y, Takada A. Nicotine attenuates stress-induced changes in plasma amino acid concentrations and locomotor activity in rats. Brain Res Bull 2000, 51(1):83-88
9. Pawlak R, Takada Y, Takahashi H, Urano T, Ihara H, Nagai N, Takada A. Differential effects of nicotine against stress-induced changes in dopaminergic system in rat striatum and hippocampus. Eur J Pharmacol 2000, 387: 171-177
10. Azzadin A, Wollny T, Pawlak R, Malyszko JS, Malyszko J, Mysliwiec M, Buczko W. L-Carnitine effects on anemia in uremic rats treated with erythropoietin. Nephron 1999;83(4):370-1
11. Malinowska B, Napiorkowska-Pawlak D, Pawlak R, Buczko W, Gothert M. Ifenprodil influences changes in mouse behaviour related to acute and chronic ethanol administration. Eur J Pharmacol 1999, 377(1):13-9
12. Chabielska E, Pawlak R, Wollny T, Rolkowski R, Buczko W. Antithrombotic activity of losartan in two kidney, one clip hypertensive rats. A study on the mechanism of action. J Physiol Pharmacol 1999, 50(1):99-109
13. Chabielska E, Pawlak R, Golatowski J, Rolkowski R, Pawlak D, Buczko W. Losartan inhibits experimental venous thrombosis in spontaneously hypertensive rats. Thromb Res 1998, 90(6):271-8
14. Chabielska E, Pawlak R, Golatowski J, Buczko W. The antithrombotic effect of captopril and losartan on experimental arterial thrombosis in rats. J Physiol Pharmacol 1998, 49(2):251-60
15. Pawlak R, Chabielska E, Golatowski J, Azzadin A, Buczko W. Nitric oxide and prostacyclin are involved in antithrombotic action of captopril in venous thrombosis in rats. Thromb Haemost 1998, 79(6):1208-12
16. Buczko W, Pawlak R, Chabielska E, Azzadin A, Famulski W. Cardiac side effects of L-NMMA. Crit Care Med 1998, 26(1):189-91
17. Pawlak R, Buczko W. Układ renina-angiotensyna a hemostaza. Kardiologia Polska (Polish Heart Journal) 1998, 48 (Suppl II): II 27- II 32
18. Napiórkowska-Pawlak D, Pawlak R, Malinowska B. Rola receptorów glutamatergicznych NMDA w działaniu alkoholu etylowego na ośrodkowy układ nerwowy. Farmakoterapia w Psychiatrii i Neurologii 1998, 4:79-91
19. Krygicz D, Azzadin A, Pawlak R, Malyszko JS, Pawlak D, Mysliwiec M, Buczko W. Cyclosporine A affects serotonergic mechanisms in uremic rats. Pol J Pharmacol 1996, 48(3):351-4
    
20. Pietraszek M, Chabielska E, Azzadin A, Pawlak R, Buczko W. Effect of endothelin-1 on some hemostatic parameters in normotensive rats. Acta Physiol Hung 1996, 84(3):329-30
21. Pawlak R, Chabielska E, Rółkowski R, Buczko W. Influence of captopril on some haemostatic parameters in rats with ongoing process of venous thrombosis. Acta Physiol Hung 1996, 84(3):327-8
22. Pietraszek M, Chabielska E, Azzadin A, Pawlak R, Buczko W. The influence of endothelin-1 on hemostasis and fibrinolysis of the rat. Acta Angiologica 1996, 4: 243-248
23. Chabielska E, Pawlak R, Buczko W. Losartan does not influence the blood platelet aggregation in normotensive rats. Acta Physiol Hung 1996, 84(3):271-2
24. Pawlak R, Chabielska E, Buczko W. Antithrombotic effect of enalapril, an angiotensin-converting enzyme inhibitor, on venous thrombosis in rats. Pol J Pharmacol 1996, 48(1):117-20
25. Chabielska E, Pawlak R, Buczko W. Effects of drugs affecting the renin-angiotensin system on venous thrombosis in normotensive rats. Pol J Pharmacol 1996, 48(1):89-91
26. Chabielska E, Pawlak R. Losartan, new angiotensin receptor antagonist - a challenge for angiotensin converting enzyme inhibitors? Wiad Lek 1995, 48(1-12):242-5